HROW
Price
$30.31
Change
-$0.85 (-2.73%)
Updated
Jun 13 closing price
Capitalization
467.85M
59 days until earnings call
OGI
Price
$1.40
Change
-$0.07 (-4.76%)
Updated
Jun 13 closing price
Capitalization
200.85M
Interact to see
Advertisement

HROW vs OGI

Header iconHROW vs OGI Comparison
Open Charts HROW vs OGIBanner chart's image
Harrow
Price$30.31
Change-$0.85 (-2.73%)
Volume$291.17K
Capitalization467.85M
Organigram Global
Price$1.40
Change-$0.07 (-4.76%)
Volume$855.94K
Capitalization200.85M
HROW vs OGI Comparison Chart
Loading...
HROW
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
OGI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
HROW vs. OGI commentary
Jun 15, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HROW is a Hold and OGI is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 15, 2025
Stock price -- (HROW: $30.31 vs. OGI: $1.40)
Brand notoriety: HROW and OGI are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: HROW: 66% vs. OGI: 162%
Market capitalization -- HROW: $467.85M vs. OGI: $200.85M
HROW [@Pharmaceuticals: Other] is valued at $467.85M. OGI’s [@Pharmaceuticals: Other] market capitalization is $200.85M. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.76B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

HROW’s FA Score shows that 1 FA rating(s) are green whileOGI’s FA Score has 0 green FA rating(s).

  • HROW’s FA Score: 1 green, 4 red.
  • OGI’s FA Score: 0 green, 5 red.
According to our system of comparison, OGI is a better buy in the long-term than HROW.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

HROW’s TA Score shows that 6 TA indicator(s) are bullish while OGI’s TA Score has 4 bullish TA indicator(s).

  • HROW’s TA Score: 6 bullish, 4 bearish.
  • OGI’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, HROW is a better buy in the short-term than OGI.

Price Growth

HROW (@Pharmaceuticals: Other) experienced а +2.43% price change this week, while OGI (@Pharmaceuticals: Other) price change was +3.70% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -0.40%. For the same industry, the average monthly price growth was +14.50%, and the average quarterly price growth was +66.97%.

Reported Earning Dates

HROW is expected to report earnings on Aug 12, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (-0.40% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
HROW($468M) has a higher market cap than OGI($201M). HROW YTD gains are higher at: -9.657 vs. OGI (-13.043). HROW has higher annual earnings (EBITDA): 9.95M vs. OGI (-195.74M). HROW has more cash in the bank: 82.8M vs. OGI (42.3M). OGI has less debt than HROW: OGI (136K) vs HROW (191M). OGI has higher revenues than HROW: OGI (161M) vs HROW (130M).
HROWOGIHROW / OGI
Capitalization468M201M233%
EBITDA9.95M-195.74M-5%
Gain YTD-9.657-13.04374%
P/E Ratio39.53N/A-
Revenue130M161M81%
Total Cash82.8M42.3M196%
Total Debt191M136K140,441%
FUNDAMENTALS RATINGS
HROW vs OGI: Fundamental Ratings
HROW
OGI
OUTLOOK RATING
1..100
1820
VALUATION
overvalued / fair valued / undervalued
1..100
77
Overvalued
50
Fair valued
PROFIT vs RISK RATING
1..100
51100
SMR RATING
1..100
9783
PRICE GROWTH RATING
1..100
3941
P/E GROWTH RATING
1..100
1136
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

OGI's Valuation (50) in the null industry is in the same range as HROW (77) in the Pharmaceuticals Other industry. This means that OGI’s stock grew similarly to HROW’s over the last 12 months.

HROW's Profit vs Risk Rating (51) in the Pharmaceuticals Other industry is somewhat better than the same rating for OGI (100) in the null industry. This means that HROW’s stock grew somewhat faster than OGI’s over the last 12 months.

OGI's SMR Rating (83) in the null industry is in the same range as HROW (97) in the Pharmaceuticals Other industry. This means that OGI’s stock grew similarly to HROW’s over the last 12 months.

HROW's Price Growth Rating (39) in the Pharmaceuticals Other industry is in the same range as OGI (41) in the null industry. This means that HROW’s stock grew similarly to OGI’s over the last 12 months.

HROW's P/E Growth Rating (11) in the Pharmaceuticals Other industry is in the same range as OGI (36) in the null industry. This means that HROW’s stock grew similarly to OGI’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
HROWOGI
RSI
ODDS (%)
Bearish Trend 2 days ago
80%
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
81%
MACD
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
86%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
83%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
81%
Advances
ODDS (%)
Bullish Trend 4 days ago
83%
Bullish Trend 4 days ago
83%
Declines
ODDS (%)
Bearish Trend 2 days ago
81%
N/A
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
82%
View a ticker or compare two or three
Interact to see
Advertisement
HROW
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
OGI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
EGORX18.20-0.20
-1.09%
Allspring Large Cap Core R6
ATHIX28.82-0.34
-1.17%
American Century Heritage I
MGFLX9.95-0.16
-1.58%
MassMutual Global Adm
AGRCX10.25-0.17
-1.63%
AB Growth C
PQJCX13.34-0.28
-2.06%
PGIM Jennison Small-Cap Core Equity R6

HROW and

Correlation & Price change

A.I.dvisor indicates that over the last year, HROW has been loosely correlated with AMRX. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if HROW jumps, then AMRX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HROW
1D Price
Change %
HROW100%
-2.73%
AMRX - HROW
45%
Loosely correlated
-2.64%
EBS - HROW
40%
Loosely correlated
-5.30%
OGI - HROW
33%
Loosely correlated
-4.76%
TLRY - HROW
32%
Poorly correlated
-2.95%
AMPH - HROW
32%
Poorly correlated
-2.34%
More

OGI and

Correlation & Price change

A.I.dvisor indicates that over the last year, OGI has been loosely correlated with CGC. These tickers have moved in lockstep 63% of the time. This A.I.-generated data suggests there is some statistical probability that if OGI jumps, then CGC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To OGI
1D Price
Change %
OGI100%
-4.76%
CGC - OGI
63%
Loosely correlated
-3.27%
TLRY - OGI
60%
Loosely correlated
-2.95%
CRON - OGI
59%
Loosely correlated
-3.02%
ACB - OGI
52%
Loosely correlated
-3.94%
HROW - OGI
33%
Loosely correlated
-2.73%
More